Achieve Life Sciences, Inc.
ACHV
$2.09
-$0.05-2.34%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -125.71% | -76.03% | -2.69% | 27.78% | 51.25% |
| Total Depreciation and Amortization | 1.75% | -1.72% | 3.64% | -1.72% | -12.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.70% | -0.47% | 23.39% | 31.34% | -9.12% |
| Change in Net Operating Assets | 1,937.68% | 8,450.00% | 1,684.21% | 11.14% | 106.50% |
| Cash from Operations | -110.56% | -101.95% | 26.29% | 36.31% | 60.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 195,383.33% | 88,573.33% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 72,770.13% | -100.00% |
| Repurchase of Common Stock | -- | -- | 30.45% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -101.00% | 119,282.98% | -100.00% |
| Foreign Exchange rate Adjustments | 66.67% | 200.00% | -- | -- | -175.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.38% | -1.16% | -703.51% | 715.50% | -166.52% |
